10x Genomics Inc (LTS:0A88)
$ 14.72 0.6324 (4.47%) Market Cap: 1.78 Bil Enterprise Value: 1.46 Bil PE Ratio: 0 PB Ratio: 2.46 GF Score: 60/100

Q3 2022 10X Genomics Inc Earnings Call Transcript

Nov 02, 2022 / 08:30PM GMT
Release Date Price: $27.15 (-4.33%)
Operator

Good evening, and thank you for attending today's 10x Genomics Third Quarter 2022 Earnings Conference Call. My name is Daniel, and I will be your moderator for today's call. (Operator Instructions). I would now like to pass the conference over to our host, Cassie Corneau, Head of Investor Relations and Strategic Finance. Cassie, please proceed.

Cassie Corneau
10x Genomics, Inc. - Manager of IR and Strategic Finance

Thank you, and good afternoon, everyone. Earlier today, 10x Genomics released financial results for the third quarter ended September 30, 2022. If you have not received this news release or if you would like to be added to the company's distribution list, please send an e-mail to [email protected]. An archived webcast of this call will be available on the Investor tab of the company's website, 10xgenomics.com, for at least 45 days following this call.

Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot